New York, NY (PRWEB) December 21, 2013
In a Biomet hip lawsuit litigation (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) that recently began the process of selecting its first bellwether trials, the number of cases filed in Indiana federal court is closing in on 900, Bernstein Liebhard LLP reports.
According to an update issued December 16th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), a total of 893 lawsuits involving the Biomet M2a Magnum hip replacement are now pending in the U.S. District Court, Northern District of Indiana. Plaintiffs in these cases similarly allege chronic pain, loss of mobility, metallosis and other serious complications caused by the metal-on-metal design of the hip, which they say creates the potential for toxic metal ions to accumulate in the surrounding tissue and blood stream. According to claims, revision surgery to remove and replace the Biomet hip is often necessary to correct these complications. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“As our Firm continues to hear from individuals who allege complications associated with premature failure of the Biomet M2a Magnum hip replacement, we are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices including the Biomet M2a Magnum Hip Replacement System. Right now, the Firm is eager to speak with anyone who received this metal-on-metal device, and is offering free and confidential case reviews to potential claimants.
Biomet Hip Lawsuits
As the number of federally-filed Biomet hip replacement lawsuits continues to grow, court documents indicate that deadlines pertaining to the litigation’s bellwether trial selection process have been set. According to a Scheduling Order issued on December 10th, the federal judge overseeing the proceeding has directed parties to choose three cases involving the M2a Magnum hip implant as trial candidates by February 7, 2014. The Order indicates that as many as five trials could be scheduled over the next year, most likely taking place in June, August, October and December of 2015, as well as in January 2016.
Meanwhile, the Biomet implant and other similarly-designed devices have come under fire over the past several months for their potential to cause complications. A safety communication led by the U.S. Food and Drug Administration (FDA) in January 2013 found that metal-on-metal hip recipients may be more likely to experience device failure within several years of implantation than those created with other materials.
Patients who may have experienced chronic pain, loss of mobility and/or symptoms associated with metallosis may be eligible to receive compensation for injuries associated with the Biomet M2a Magnum hip replacement. Learn more about the mounting lawsuits filed over this implant by visiting Bernstein Liebhard LLP’s website, or by calling the Firm directly at 800-511-5092 to arrange for a free and confidential case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP